Secretory leukocyte protease inhibitor promotes the tumorigenic and metastatic potential of cancer cells

被引:86
作者
Devoogdt, N [1 ]
Ghassabeh, GH [1 ]
Zhang, J [1 ]
Brys, L [1 ]
De Baetselier, P [1 ]
Revets, H [1 ]
机构
[1] Vrije Univ Brussels VIB, Dept Mol & Cellular Interact, B-1050 Brussels, Belgium
关键词
D O I
10.1073/pnas.1037154100
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Because of their ability to inhibit proteases, protease inhibitors have generally been considered to counteract tumor progression and metastasis. However, expression of serine protease inhibitors (SPIs) in tumors is often associated with poor prognosis of cancer patients. Moreover, there is growing evidence that SPIs may even promote malignancy of cancer cells, opening new avenues for their use as biomarkers in malignancy. To isolate cancer promoting genes, we applied the suppression subtractive hybridization method to low-malignant Lewis Lung Carcinoma 3LL-S versus high-malignant 3LL-S-sc cells. This resulted in the identification of the SPI secretory leukocyte protease inhibitor (SLPI), as one of the genes whose expression was higher in 3LL-S-sc than in 3LL-S cells. By stable transfection of 3LL-S cells with mouse or human SLPI, we demonstrated that elevated levels of SLPI expression increased both the tumorigenicity and lung-colonizing potential of 3LL-S cells. Moreover, we showed that this function of SLPI depended on its protease inhibitory capacity. Our results also reveal that although SLPI enhanced the proliferation of 3LL-S cells in vitro, its promalignant activity in vivo was not solely due to its effect on cell proliferation. In this study, we report a causal role for SLPI in the malignant behavior of cancer cells, underscoring the potential malignancy-promoting activities of SPIs.
引用
收藏
页码:5778 / 5782
页数:5
相关论文
共 40 条
[11]  
2-N
[12]  
Hough CD, 2001, CANCER RES, V61, P3869
[13]  
Hough CD, 2000, CANCER RES, V60, P6281
[14]   Cancer invasion and tissue remodeling: common themes in proteolytic matrix degradation [J].
Johnsen, M ;
Lund, LR ;
Romer, J ;
Almholt, K ;
Dano, K .
CURRENT OPINION IN CELL BIOLOGY, 1998, 10 (05) :667-671
[15]   PROGNOSTIC-SIGNIFICANCE OF ALPHA-1-ANTITRYPSIN IN EARLY STAGE OF COLORECTAL CARCINOMAS [J].
KARASHIMA, S ;
KATAOKA, H ;
ITOH, H ;
MARUYAMA, R ;
KOONO, M .
INTERNATIONAL JOURNAL OF CANCER, 1990, 45 (02) :244-250
[16]   Enhanced tumor growth and invasiveness in vivo by a carboxyl-terminal fragment of α1-proteinase inhibitor generated by matrix metalloproteinases -: A possible modulatory role in natural killer cytotoxicity [J].
Kataoka, H ;
Uchino, H ;
Iwamura, T ;
Seiki, M ;
Nabeshima, K ;
Koono, M .
AMERICAN JOURNAL OF PATHOLOGY, 1999, 154 (02) :457-468
[17]   Emerging multifunctional aspects of cellular serine proteinase inhibitors in tumor progression and tissue regeneration [J].
Kataoka, H ;
Itoh, H ;
Koono, M .
PATHOLOGY INTERNATIONAL, 2002, 52 (02) :89-102
[18]   Secretory leukocyte protease inhibitor in mice regulates local and remote organ inflammatory injury induced by hepatic ischemia/reperfusion [J].
Lentsch, AB ;
Yoshidome, H ;
Warner, RL ;
Ward, PA ;
Edwards, MJ .
GASTROENTEROLOGY, 1999, 117 (04) :953-961
[19]   Inhibition of NF-κB activation and augmentation of IκBβ by secretory leukocyte protease inhibitor during lung inflammation [J].
Lentsch, AB ;
Jordan, JA ;
Czermak, BJ ;
Diehl, KM ;
Younkin, EM ;
Sarma, V ;
Ward, PA .
AMERICAN JOURNAL OF PATHOLOGY, 1999, 154 (01) :239-247
[20]   The microenvironment of the tumour-host interface [J].
Liotta, LA ;
Kohn, EC .
NATURE, 2001, 411 (6835) :375-379